Disease/Infection News

RSS

Engineered mice reveal how Omicron subvariant BA.5 is more virulent

New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.

25 Sep 2023

COVID drug molnupiravir appears to be driving SARS-CoV-2 to mutate and evolve

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown. It is not clear, however, whether these mutated viruses pose an increased risk to patients or are able to evade the vaccine.

25 Sep 2023

Future-proof vaccine candidate protects against wide range of coronaviruses

Studies of a 'future-proof' vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.

25 Sep 2023

Long COVID patients exhibit different immune and hormonal responses to the virus, study shows

People who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with the COVID-19 virus exhibit different immune and hormonal responses to the virus than those not diagnosed with long COVID, according to a new study by researchers at Yale School of Medicine and Icahn School of Medicine at Mount Sinai.

25 Sep 2023

New injectable solution could help manage HIV unlike any current treatment methods

A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found.

25 Sep 2023

Is the implementation of contact precautions crucial for preventing healthcare-associated MRSA?

The designation of contact precautions as an "essential practice" for MRSA prevention.

25 Sep 2023

The power of nanobodies: How they impact COVID-19 immune response

The structures of 340 antibodies (Abs) and 83 nanobodies.

25 Sep 2023

COVID-19 pushed upstate New Yorkers to embrace backyard farming

During the COVID-19 pandemic, upstate New Yorkers turned to backyard and wild food production to gain more control over their food supply, according to a study by Cornell University. The research highlights how the pandemic-related disruptions in conventional food supply chains led to a significant uptick in gardening, poultry rearing, and foraging as a strategy to improve food security.

25 Sep 2023

How are SARS-CoV-2 variants outsmarting our immune system and vaccines?

Researchers use multiomics analysis to understand how SARS-CoV-2 variants, including Alpha, Delta, and Omicron, modulate the host's cellular responses and adapt to evade human immunity. The study highlights the potential for targeted therapies against both adaptive and innate immune responses.

25 Sep 2023

Exercise boosts immune defense in Lynch syndrome patients

Aerobic exercise, specifically cycling, shows promise in reducing inflammation and boosting immune responses in the colonic tissue of Lynch syndrome patients, a group at high risk for colorectal cancer. The study suggests that regular exercise may offer a preventive approach for this patient population, though further randomized trials are needed.

24 Sep 2023

TB cases in England increase by 7% in the first half of 2023

Data from the UK Health Security Agency (UKHSA) indicates that cases of TB in England increased by 7% in the first half of 2023 compared to the same timeframe in 2022, with 2,408 notifications compared to 2,251 in the first 2 quarters of 2022.

22 Sep 2023

Using recombinase polymerase amplification for rapid and visual detection of monkey B virus

Announcing a new article publication for Zoonoses journal. Monkey B virus (BV) infection in humans and other macaque species has a mortality rate of approximately 80%.

22 Sep 2023

Omics analysis identifies new biomarkers for predicting mortality in patients with pneumonia

Community-acquired pneumonia (CAP) is a major infectious disease worldwide and contributes to high mortality and massive economic burden. Hospital mortality among the severe CAP (SCAP) remains high, ranging from 25% to more than 50%.

22 Sep 2023

Discovery lead to better methods for reducing mosquito-to-human transmission of deadly viruses

Researchers from the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health have made an important finding about Aedes aegypti mosquitoes-;one that could one day lead to better methods for reducing the mosquito-to-human transmission of dengue, yellow fever, Zika, and other harmful and sometimes deadly viruses.

22 Sep 2023

COVID-19 pandemic has increased mental health burden on family and friends of patients

Family members and close friends of people with COVID-19 have elevated symptoms of depression and anxiety, a study from Karolinska Institutet published in The Lancet Regional Health - Europe reports.

22 Sep 2023

Clinical study launched to test the benefits of immune modulation for hospitalized COVID-19 patients

A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial.

22 Sep 2023

Could creatine supplementation be the answer to post-COVID-19 fatigue?

In a recent study published in the journal Food Science & Nutrition, researchers investigated creatine supplementations as a potential intervention strategy to attenuate the clinical symptoms of post-COVID-19 fatigue syndrome.

22 Sep 2023

VAX-seq: the future of mRNA vaccine analysis and quality assurance?

Researchers proposed a simplified approach for analyzing mRNA vaccines using long-read sequencing.

22 Sep 2023

Can COVID-19 vaccines turn the tide on long-haul symptoms?

The study finds that COVID-19 vaccination can significantly reduce symptoms and improve well-being in patients suffering from post-COVID-19 conditions (PCC). Vaccination also lowered systemic markers of inflammation but did not entirely eliminate persistent SARS-CoV-2 antigens, which may continue to contribute to inflammation.

22 Sep 2023

Long COVID sidelining doctors and putting careers at risk, says alarming BMJ study

Doctors grappling with long COVID face significant career setbacks and inadequate workplace protection, according to a recent BMJ study. Co-founded by a doctor who contracted long COVID, advocacy group Long COVID Doctors for Action pushes for better support and recognition of the condition as an occupational disease.

21 Sep 2023

Disease/Infection News

Engineered mice reveal how Omicron subvariant BA.5 is more virulent

COVID drug molnupiravir appears to be driving SARS-CoV-2 to mutate and evolve

Future-proof vaccine candidate protects against wide range of coronaviruses

Long COVID patients exhibit different immune and hormonal responses to the virus, study shows

New injectable solution could help manage HIV unlike any current treatment methods

Is the implementation of contact precautions crucial for preventing healthcare-associated MRSA?

The power of nanobodies: How they impact COVID-19 immune response

COVID-19 pushed upstate New Yorkers to embrace backyard farming

How are SARS-CoV-2 variants outsmarting our immune system and vaccines?

Exercise boosts immune defense in Lynch syndrome patients

TB cases in England increase by 7% in the first half of 2023

Using recombinase polymerase amplification for rapid and visual detection of monkey B virus

Omics analysis identifies new biomarkers for predicting mortality in patients with pneumonia

Discovery lead to better methods for reducing mosquito-to-human transmission of deadly viruses

COVID-19 pandemic has increased mental health burden on family and friends of patients

Clinical study launched to test the benefits of immune modulation for hospitalized COVID-19 patients

Could creatine supplementation be the answer to post-COVID-19 fatigue?

VAX-seq: the future of mRNA vaccine analysis and quality assurance?

Can COVID-19 vaccines turn the tide on long-haul symptoms?

Long COVID sidelining doctors and putting careers at risk, says alarming BMJ study

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News